Real-time enrollment status for this autism spectrum disorder clinical trial
Current Status
Unknown
Checked: April 17, 2026 at 5:09 AM UTC
| NCT Number | NCT05361707 |
| Recruiting Status | Unknown |
| Condition | Autism Spectrum Disorder |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Vanda Pharmaceuticals |
| Last Updated on CT.gov | March 21, 2024 (Mar 21, 2024) |
As of April 17, 2026: Clinical trial NCT05361707 is currently unknown participants. This clinical trial study for autism spectrum disorder is not currently accepting new participants at 5 locations across the United States. The study is sponsored by Vanda Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05361707 is currently unknown. The study may resume recruiting in the future.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05361707 was last updated Mar 21, 2024 (March 21, 2024). HelloStudys verifies this status automatically.